Clinical Trial Update: Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating oral azacitidine in transplant-eligible adults with acute myeloid leukemia experiencing health inequality, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Oral azacitidine (azacitidine (oral formulation))

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: RECRUITING